On September 2 (Tuesday), GAIA-BT (represented by CEO Yun Kyoung Kang), an innovative biotech AI company, and YUHAN CARE (represented by CEO Jeong Su Son), a leader in the healthcare and lifestyle sector, signed an MOU for the joint development of next-generation functional food ingredients, powered by GAIA-BT's proprietary 3-step Reasoning RAG AI platform.

Through this strategic partnership, the two companies will pursue:

• The automation and advancement of R&D for functional foods and health-functional ingredients using a next-generation AI agent.

• The establishment of a future-oriented R&D platform (IaaS) that applies generative AI and big data convergence technologies.

• Joint research to create new value through the exploration, discovery, and functional prediction of novel food ingredient candidates.

The core of this collaboration, GAIA-BT's 3-step Reasoning RAG, is expected to deliver significant added value across the food and biotech industries. Its key benefits include combining existing data with the latest scientific knowledge, enhancing natural language query processing, and refining the precision of automated R&D processes. (EDonga)(E2NEWS)

A word from our CEO, Yun Kyoung Kang: 

"YUHAN CARE's robust R&D infrastructure is the optimal environment for our 'Bio-material Development Specialist Agent,' GAIA-Elix, to achieve peak performance in a real-world industrial setting. The 3-step reasoning RAG technology applied in this collaboration simulates the thought processes of human experts, dramatically increasing the success rate of new material development and commercialization. Through the synergy between our companies, we aim to establish ourselves as a game-changer leading innovation in both domestic and international food & bio markets."